1. HBW Insight

Califf Deftly Navigates Sunscreen Catechism In Confirmation Hearing

 
• By Eileen Francis

FDA commissioner nominee Robert Califf emphasizes that adequate evidence is key to moving sunscreen TEAs through FDA’s evaluation process, addressing the issue during his Senate confirmation hearing. He also fielded questions about use of FDA rulemaking authority versus guidance and seemed to pass inspection regarding previous industry connections, though Democratic presidential candidate Bernie Sanders continues to have reservations.

FDA commissioner nominee Robert Califf told Senate members the agency is open to moving quickly on sunscreen ingredient evaluations when sponsors provide the appropriate safety and efficacy evidence.

Califf addressed the issue during his Nov. 17 confirmation hearing before the Senate Health, Education, Labor and Pensions Committee, a...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from HBW Insight

FDA Urged To Issue Formaldehyde Rule As California Finds Non-Compliance With State Ban

 
• By Lauren Nardella

Stakeholders are still waiting for the US FDA to issue its widely anticipated proposed rule to prohibit formaldehyde and formaldehyde releasers from hair smoothing or straightening products.

Cloudy Tariff Conditions Expected To Linger In US

 
• By Malcolm Spicer

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.

Over The Counter: How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

HBW Insight speaks to Bayer Consumer Health's global strategy director for regulatory, medical, safety, quality, and compliance Emese Csoke about how least how widening access to self-care solutions can be balanced with equity with regards to affordability.